12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
周三盘后交易时段，12只医疗保健类股走势
Gainers
获胜者
- HTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 33.0% to $6.01 during Wednesday's after-market session. This security traded at a volume of 323.6K shares come close, making up 21.6% of its average volume over the last 100 days. The company's market cap stands at $6.1 million.
- Lannett (NYSE:LCI) shares rose 15.74% to $0.62. The market value of their outstanding shares is at $26.2 million. As per the press release, Q2 earnings came out today.
- Align Tech (NASDAQ:ALGN) shares rose 15.03% to $325.0. At the close, Align Tech's trading volume reached 121.5K shares. This is 11.8% of its average volume over the last 100 days. The company's market cap stands at $25.3 billion. The company's, Q4 earnings came out today.
- Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 12.69% to $0.53. Today's trading volume for this security ended up closing at 1.7 million shares, which is 1118.5 percent of its average volume over the last 100 days. The company's market cap stands at $14.2 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) stock rose 12.29% to $0.49. The market value of their outstanding shares is at $44.8 million.
- Opthea (NASDAQ:OPT) stock increased by 10.66% to $5.81. The company's market cap stands at $294.1 million.
- HTG 分子诊断 纳斯达克股票代码：HTGM）的股价在周三的盘后交易时段上涨了33.0％，至6.01美元。该证券的交易量接近323.6万股，占其过去100天平均交易量的21.6％。该公司的市值为610万美元。
- 兰内特 纽约证券交易所代码：LCI）股价上涨15.74％，至0.62美元。他们已发行股票的市值为2620万美元。根据新闻稿，第二季度财报今天公布。
- Alight 纳斯达克股票代码：ALGN）股价上涨15.03％，至325.0美元。收盘时，Align Tech的交易量达到121.5万股。这是其过去 100 天平均交易量的11.8％。该公司的市值为253亿美元。该公司的第四季度财报今天公布。
- 阿迪尔制药 纳斯达克股票代码：ADIL）股价上涨12.69％，至0.53美元。该证券今天的交易量最终收于170万股，占其过去100天平均交易量的1118.5％。该公司的市值为1420万美元。
- Nymox 制药 纳斯达克股票代码：NYMX）股价上涨12.29％，至0.49美元。他们已发行股票的市值为4,480万美元。
- Opthea 纳斯达克股票代码：OPT）的股票上涨了10.66％，至5.81美元。该公司的市值为2.941亿美元。
Losers
失败者
- Bright Green (NASDAQ:BGXX) shares fell 12.0% to $1.25 during Wednesday's after-market session. Trading volume for this security closed at 1.2 million, accounting for 398.9% of its average full-day volume over the last 100 days. The company's market cap stands at $211.6 million.
- Calithera Biosciences (NASDAQ:CALA) shares decreased by 9.62% to $0.33. The market value of their outstanding shares is at $1.6 million.
- Metacrine (NASDAQ:MTCR) stock decreased by 7.7% to $0.48. This security traded at a volume of 157.9K shares come close, making up 46.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.4 million.
- Vera Therapeutics (NASDAQ:VERA) stock fell 7.43% to $7.85. The market value of their outstanding shares is at $217.1 million.
- Purple Biotech (NASDAQ:PPBT) shares declined by 7.15% to $1.56. The market value of their outstanding shares is at $28.6 million.
- Terns Pharma (NASDAQ:TERN) stock declined by 6.94% to $8.32. The company's market cap stands at $411.9 million. See Also:
- 亮绿色 纳斯达克股票代码：BGXX）股价在周三的盘后交易时段下跌12.0％，至1.25美元。该证券的交易量收于120万，占其过去100天平均全日交易量的398.9％。该公司的市值为2.116亿美元。
- Calithera 生物科学 纳斯达克股票代码：CALA）股价下跌9.62％，至0.33美元。他们已发行股票的市值为160万美元。
- Metacrine 纳斯达克股票代码：MTCR）股价下跌7.7％，至0.48美元。该证券的交易量接近157.9万股，占其过去100天平均交易量的46.3％。他们已发行股票的市值为2,040万美元。
- 维拉疗法 纳斯达克股票代码：VERA）股价下跌7.43％，至7.85美元。他们已发行股票的市值为2.171亿美元。
- 紫色生物科技 纳斯达克股票代码：PPBT）股价下跌7.15％，至1.56美元。他们已发行股票的市值为2860万美元。
- 特伦斯制药 纳斯达克股票代码：TERN）股价下跌6.94％，至8.32美元。该公司的市值为4.119亿美元。 另请参阅：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。